IMMX
Immix BiopharmaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
IMMX vs peer average
76/100
IMMX vs. peer average (A vs. C)
Grade spread
A 3 · B 3 · C 1 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AVIR is the first available peer comparator.
Another loose small-cap biotech comparison where valuation can move sharply around development updates and capital-markets access, but not a close operating comp.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMMX
Immix Biopharma
AVIR
Atea
Grade
A
D
Momentum
84
12
Value
41
41
Sentiment
61
67
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AVIR
IMMX / AVIR
Grade Position
Above peers
IMMX vs. peer average (A vs. C)
76/100
Momentum
84
IMMXValue
41
IMMXSentiment
61
AVIRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMMX
AVIR is the first peer returned for this comparison set.